A tertiary centre experience of robotic Aquablation: Standard operating versus high-intensity theatre protocol
Published online on January 24, 2026
Abstract
Journal of Clinical Urology, Ahead of Print.
Objective:Aquablation is FDA and NICE approved for treating benign prostatic hyperplasia (BPH). In the UK, increasing surgical elective waiting lists have created the need for HIT list models. We present a tertiary centre experience using Aquablation ...
Objective:Aquablation is FDA and NICE approved for treating benign prostatic hyperplasia (BPH). In the UK, increasing surgical elective waiting lists have created the need for HIT list models. We present a tertiary centre experience using Aquablation ...